Investigating mechanisms of chronic kidney disease in mouse models

Allison A Eddy1, Jesús M López-Guisa, Daryl M Okamura

  • 1Center for Tissue and Cell Sciences, Seattle Children's Research Institute, 1900 Ninth Avenue, M/S C9S-5, Seattle, WA 98101-1309, USA. allison.eddy@seattlechildrens.org

Insights

Animal models are crucial for studying chronic kidney disease (CKD) and testing therapies. This review highlights mouse models, including unilateral ureteral obstruction (UUO), and alternatives for comprehensive research.

Area of Science:

  • Nephrology
  • Translational Medicine
  • Animal Models

Background:

  • Animal models are essential for understanding chronic kidney disease (CKD) mechanisms and validating therapeutic interventions.
  • Mouse models, particularly unilateral ureteral obstruction (UUO), are widely used due to their ability to mimic CKD pathogenesis rapidly.
  • The UUO model has limitations, especially in assessing renal function and fibrosis quantitatively.

Purpose of the Study:

  • To review various mouse models for chronic kidney disease (CKD) research.
  • To discuss the utility of genetic and experimentally induced models.
  • To highlight models that allow for comprehensive assessment of renal function and fibrosis.

Main Methods:

  • Review of existing literature on mouse models of chronic kidney disease (CKD).
  • Comparison of the unilateral ureteral obstruction (UUO) model with alternative genetic and induced models.
  • Identification of models suitable for evaluating both renal function and fibrosis.

Main Results:

  • The unilateral ureteral obstruction (UUO) model is a high-throughput tool for studying CKD mechanisms.
  • Alternative mouse models offer advantages over UUO, enabling quantitative assessment of renal function and fibrosis.
  • Both genetic and experimentally induced models provide valuable research opportunities.

Conclusions:

  • A variety of mouse models exist for chronic kidney disease (CKD) research, each with specific strengths.
  • Models beyond UUO are necessary for a complete understanding of CKD pathogenesis and therapeutic efficacy.
  • Investigators can select appropriate models to incorporate both functional and structural endpoints in their studies.